£2.0M
The pre-series a financing was led by Science Angel Syndicate and Fink Family Office to support pre-clinical studies for the GRACE implant.
QV Bioelectronics
QV Bioelectronics builds surgically implanted electric field therapy devices to treat brain tumours.
£2.7MTotal raised
QV Bioelectronics develops surgical medical devices using electric field therapy to treat brain tumours. Its lead product is an implantable device aimed at glioblastoma.
Categories
Founders
Christopher Bullock
CEO
Christopher co-founded QV Bioelectronics, where he serves as CTO after previously holding the position of CEO. He also co-founded PhD Pigeon Ltd and spent time as a visiting researcher at the Institut Català de Nanociència i Nanotecnologia.
LinkedInRF
Richard Fu
Clinical Director
Investors
- £2.0M
- £735K
Funding history
£735K
The oversubscribed round was backed by Consilience Ventures, SOSV, and Catapult Ventures to support the development of the GRACE device.